No consistent histological differences between both groups were observed.
In addition, statistically significant differences (p < 0.05, Mann–Whitney U-test) between both groups were found in relative power of theta band.
Clinical features between both groups were compared by descriptive statistics.
Differences between both groups were assessed using the Mann–Whitney U test.
However, no significant differences in clinical and microbiological outcomes between both groups were found.
Most variables between both groups were comparable except cerebrospinal fluid glucose/plasma glucose.
Therefore, partial measurement invariance across the elementary school and the middle school sample was established, and differences in the latent means between both groups were subsequently computed.
After therapy, withdrawal tumor growth rates still differed; however, at the end of the study at day 40, the tumor sizes between both groups were comparable again, indicating an increased tumor growth rate in the treated group (tumor growth flare).
The differences in glucose consumption between both groups were mostly related to changes in pyruvate contents, and samples cultured at 37, 40, and 43 °C exhibited the highest levels of pyruvate production at 36 h (Fig. 2c).
As in Mo7e cells, differences between both groups were significant, both in untreated and in MMC-treated cells (Figure 1b).
The differences of immunoblot band intensities between both groups were analyzed by student's t-test using SPSS software (version 13.0).
